期刊文献+

类过敏反应的研究进展 被引量:29

Research Progress about Anaphylactoid Reactions
下载PDF
导出
摘要 目的对类过敏反应的症状特点、发生机理、评价方法及存在的问题进行了综述和分析,为类过敏反应的深入研究提供文献依据。方法对近年来有关类过敏反应的国内外文献进行了整理与归纳。结果虽然类过敏反应的症状表现与过敏反应相似,但两者发生机制并不相同,其无需提前致敏、抗体介导,首次接触即可发生,危害严重。目前,类过敏反应的临床前评价方法主要有动物实验和细胞实验,检测指标有组胺、IgE等,其诊断需结合症状特点及生物指标综合判断。结论亟待建立可行的有关类过敏反应的临床前评价方法 。 Objective To provide literature evidences for in-depth study of anaphylactoid reactions through reviewing and analyzing the symptoms, mechanism, evaluation methods and problems. Methods The related references in recent years at home and abroad about anaphylactoid reactions were collected and summarized. Results Although the symptoms are similar with allergic reactions, the mechanism is not same. The anaphylactoid reactions can occur at first contact without prior sensitization and antibody-mediated, the aftermath is serious. Currently, the detecting indicators include histamine, IgE, and so on. The diagnosis requires a overall judgment of characteristic symptoms and biological indicators. Conclusion It's urgent to establish viable preclinical evaluation methods about anaphylactoid reactions.
作者 高建波
出处 《中国药物警戒》 2014年第6期344-346,共3页 Chinese Journal of Pharmacovigilance
关键词 类过敏反应 机制 评价方法 anaphylactoid reactions mechanism evaluation methods
  • 相关文献

参考文献23

  • 1Farnam K, Chang C, Teuber S, et al. Nonallergic drug hypersensi- tivity reactions[J]. Int Arch Allergy Immunol012,159(4):327-345.
  • 2李佳,黄芝瑛.注射用辅料类过敏反应的非临床评价方法[J].药物评价研究,2010,33(1):9-12. 被引量:20
  • 3程芳,史艳秋,秦慧迪,刘兆平.药物类过敏反应生物标志物探究[J].生命的化学,2008,28(6):795-798. 被引量:23
  • 4王志国,王丹巧,于友华,李贻奎,隋宇,崔海峰.组胺致Beagle犬类过敏反应实验模型研究[J].中国中药杂志,2011,36(14):1842-1844. 被引量:16
  • 5Greenberger P A. Anaphylactic and anaphylactoid causes of an- gioedema[J]. Immunol Allergy Clin North Am, 2006,26(4):753-767.
  • 6Lagopoulos V, Gigi E. Anaphylactic and anaphylactoid reactions during the perioperative period[J]. Hippokratia,2011,15(2):138-14,0.
  • 7Siemiatkowski A, Kociuczuk U. The role of tryptase assay in recognition of anaphylactic reaction to muscle relaxants[J]. Anestezjol Intens Ter, 2010, 42(1): 31-36.
  • 8Gelderblom H, Verweij J, Nooter K, et al. Cremophor EL: the draw- backs and advantages of vehicle selection for drug formulation [J]. Eur J Cancer,2001,37(13): 1590-1598.
  • 9马宏图,睢凤英.中药注射剂安全性与类过敏反应[J].中国医院药学杂志,2009,29(10):838-840. 被引量:24
  • 10Choi Y H, Yan G H, Chai O H, et al. Inhibitory effects of cur- cumin on passive cutaneous anaphylactoid response and compound 48/80-induced mast cell activation[J]. Anat Cell Biol, 2010,43(1): 36--43.

二级参考文献117

共引文献142

同被引文献396

引证文献29

二级引证文献194

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部